USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Growth Opportunities in Sterile Injectable Outsourcing
Growth Opportunities in Sterile Injectable Outsourcing
Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing
08-Jun-2022
North America
Description
Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring
of biopharmaceutical products for COVID-19 and next-generation biologics has significantly increased the demand for aseptic fill-and-finish capacity and capabilities to meet the demand from various regions. All these factors have made sterile injectable drug product services outsourcing the most lucrative opportunity for contract development and manufacturing companies (CDMO)s. The sterile injectable outsourcing market is set to expand at a CAGR of 9.4%% from 2021 to 2026.
Accelerated project timeframes have prompted CDMOs to review their approach and consider strategies that support greater agility in fill-and-finish operations. The development and manufacturing of high-potency small molecules, less-soluble drugs, and targeted small molecules have allowed small-molecule CDMOs to showcase their capabilities and expertise to pharmaceutical partners. Similarly, biologic manufacturing requires advanced manufacturing/quality control technologies, equipment and skill sets. Biopharma companies and innovative biotech players are increasingly outsourcing process development and manufacturing to CDMOs that possess excellent technologies and equipment.
In this report, Frost & Sullivan offers:
• Insights through market forecasts
• Analysis by segment: small-molecule FDF and biologic drug product
• Market trends, drivers, and restraints
• CDMOs’ investment and expansion into injectable capacity
• Opportunities that stakeholders can pursue
Author: Surbhi Gupta
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Sterile Injectables Outsourcing
Growth Opportunities Fuel the Growth Pipeline Engine™
Key Takeaways
Scope of Analysis
Forecast Framework—CDMO
Forecast Methodology—Sterile Injectable Outsourcing
Forecast Assumptions
Key Growth Metrics
Growth Drivers
Growth Restraints
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast Analysis
Therapeutic Area Overview
Therapeutic Area Overview (continued)
Supply Chain and the Evolving Role of Vendors
Recent Trends Driving Collaborations & Expansions
Recent Trends Driving Collaborations & Expansions (continued)
Capability Overview of Select CDMOs
CDMO Acquisitions and Sterile Injectable Capacity Expansion—US
CDMO Acquisitions and Sterile Injectable Capacity Expansion—US (continued)
CDMO Acquisitions and Sterile Injectable Capacity Expansion—US (continued)
CDMO Acquisitions and Sterile Injectable Capacity Expansion—Europe
CDMO Acquisitions and Sterile Injectable Capacity Expansion—Europe (continued)
CDMO Acquisitions and Sterile Injectable Capacity Expansion—APAC
Smartification of Injectable Delivery Device
Growth Opportunity 1: Flexible and Modular Aseptic Fill-and-Finish Capabilities
Growth Opportunity 1: Flexible and Modular Aseptic Fill-and-Finish Capabilities (continued)
Growth Opportunity 2: Strategic Partnerships that Provide Integrated Injectable Drug Product and Device Service
Growth Opportunity 2: Strategic Partnerships to Provide Integrated Injectable Drug Product and Device Service (continued)
Growth Opportunity 3: Cold-chain Capabilities that Support Next-gen Biologics
Growth Opportunity 3: Cold-chain Capabilities that Support Next-gen Biologics (continued)
List of Exhibits
Legal Disclaimer
Popular Topics
| Author | Surbhi Gupta |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| WIP Number | PD27-01-00-00-00 |